Inmune Bio Stock Price Prediction
| INMB Stock | USD 9.22 0.94 9.25% |
Oversold Vs Overbought
62
Oversold | Overbought |
EPS Estimate Next Quarter (0.54) | EPS Estimate Current Year (2.30) | EPS Estimate Next Year (2.04) | Wall Street Target Price 19.8333 | EPS Estimate Current Quarter (0.50) |
Using INmune Bio hype-based prediction, you can estimate the value of INmune Bio from the perspective of INmune Bio response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards INmune Bio using INmune Bio's stock options and short interest. It helps to benchmark the overall future attitude of investors towards INmune using crowd psychology based on the activity and movement of INmune Bio's stock price.
INmune Bio Implied Volatility | 1.39 |
INmune Bio's implied volatility exposes the market's sentiment of INmune Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if INmune Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that INmune Bio stock will not fluctuate a lot when INmune Bio's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in INmune Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying INmune because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
INmune Bio after-hype prediction price | USD 9.31 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current INmune contract
Based on the Rule 16, the options market is currently suggesting that INmune Bio will have an average daily up or down price movement of about 0.0869% per day over the life of the 2025-03-21 option contract. With INmune Bio trading at USD 9.22, that is roughly USD 0.00801 . If you think that the market is fully incorporating INmune Bio's daily price movement you should consider acquiring INmune Bio options at the current volatility level of 1.39%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
INmune |
INmune Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of INmune Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in INmune Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of INmune Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
INmune Bio Estimiated After-Hype Price Volatility
In the context of predicting INmune Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on INmune Bio's historical news coverage. INmune Bio's after-hype downside and upside margins for the prediction period are 3.43 and 15.19, respectively. We have considered INmune Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
INmune Bio is slightly risky at this time. Analysis and calculation of next after-hype price of INmune Bio is based on 3 months time horizon.
INmune Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as INmune Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading INmune Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with INmune Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.80 | 5.88 | 0.09 | 0.01 | 7 Events / Month | 12 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
9.22 | 9.31 | 0.98 |
|
INmune Bio Hype Timeline
INmune Bio is currently traded for 9.22. The entity has historical hype elasticity of 0.09, and average elasticity to hype of competition of -0.01. INmune is expected to increase in value after the next headline, with the price projected to jump to 9.31 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.98%, whereas the daily expected return is currently at 0.8%. The volatility of related hype on INmune Bio is about 41650.0%, with the expected price after the next announcement by competition of 9.21. The company reported the previous year's revenue of 155 K. Net Loss for the year was (30.01 M) with profit before overhead, payroll, taxes, and interest of 42 K. Given the investment horizon of 90 days the next expected press release will be in about 7 days. Check out INmune Bio Basic Forecasting Models to cross-verify your projections.INmune Bio Related Hype Analysis
Having access to credible news sources related to INmune Bio's direct competition is more important than ever and may enhance your ability to predict INmune Bio's future price movements. Getting to know how INmune Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how INmune Bio may potentially react to the hype associated with one of its peers.
INmune Bio Additional Predictive Modules
Most predictive techniques to examine INmune price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for INmune using various technical indicators. When you analyze INmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About INmune Bio Predictive Indicators
The successful prediction of INmune Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as INmune Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of INmune Bio based on analysis of INmune Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to INmune Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to INmune Bio's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Graham Number | 10.98 | 8.92 | 8.03 | 5.12 | Receivables Turnover | 0.0442 | 0.0635 | 0.073 | 0.0693 |
Story Coverage note for INmune Bio
The number of cover stories for INmune Bio depends on current market conditions and INmune Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that INmune Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about INmune Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
INmune Bio Short Properties
INmune Bio's future price predictability will typically decrease when INmune Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of INmune Bio often depends not only on the future outlook of the potential INmune Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. INmune Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18 M | |
| Cash And Short Term Investments | 35.8 M |
Complementary Tools for INmune Stock analysis
When running INmune Bio's price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |